Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$590K Buy
+181,247
New +$989K ﹤0.01% 2523
2026
Q1
Sell
-48,046
Closed -$570K 4026
2025
Q4
$570K Buy
+48,046
New +$634K ﹤0.01% 2038
2025
Q3
Sell
-39,127
Closed -$379K 3043
2025
Q2
$379K Buy
+39,127
New +$440K ﹤0.01% 1741
2023
Q4
Sell
-28,971
Closed -$436K 2496
2023
Q3
$436K Sell
28,971
-410,352
-93% -$7.7M ﹤0.01% 1473
2023
Q2
$9.49M Buy
439,323
+56,764
+15% +$1.55M 0.09% 153
2023
Q1
$10.8M Buy
+382,559
New +$10.9M 0.13% 123
2022
Q4
Sell
-630,275
Closed -$18.1M 2630
2022
Q3
$18.1M Buy
+630,275
New +$18.7M 0.2% 82

Other funds holding EMBC

HRT Financial's EMBC Position: Q2 2026 in Review

HRT Financial opened a new position in Embecta (EMBC) in Q2 2026: 181,247 shares worth $590K. The stake represents ﹤0.01% of the portfolio and ranks #2523 among its holdings. This is a return to the name: HRT Financial previously reported a position in EMBC as recently as Q4 2025.

HRT Financial first reported a position in EMBC in Q3 2022 and has held it in 7 quarters since. The position peaked at $18.1M in Q3 2022. 321 funds tracked by Wall St. Rank hold EMBC as of Q2 2026.

  • HRT Financial held 181,247 shares of Embecta worth $590K as of Q2 2026.
  • Embecta was a new HRT Financial position in Q2 2026.
  • Embecta made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #2523 holding.
  • HRT Financial first reported a position in Embecta in Q3 2022 and has held it in 7 quarters since.
  • HRT Financial's Embecta position peaked at $18.1M in Q3 2022.
  • 321 funds tracked by Wall St. Rank held Embecta as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.